These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38028973)

  • 21. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-E
    Fang YH; Wang SPH; Liao IC; Tsai KJ; Huang PH; Yang PJ; Yen CJ; Liu PY; Shan YS; Liu YW
    Adv Healthc Mater; 2023 Nov; 12(29):e2301186. PubMed ID: 37672681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.
    Feyen DAM; McKeithan WL; Bruyneel AAN; Spiering S; Hörmann L; Ulmer B; Zhang H; Briganti F; Schweizer M; Hegyi B; Liao Z; Pölönen RP; Ginsburg KS; Lam CK; Serrano R; Wahlquist C; Kreymerman A; Vu M; Amatya PL; Behrens CS; Ranjbarvaziri S; Maas RGC; Greenhaw M; Bernstein D; Wu JC; Bers DM; Eschenhagen T; Metallo CM; Mercola M
    Cell Rep; 2020 Jul; 32(3):107925. PubMed ID: 32697997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease.
    Giacomelli E; Meraviglia V; Campostrini G; Cochrane A; Cao X; van Helden RWJ; Krotenberg Garcia A; Mircea M; Kostidis S; Davis RP; van Meer BJ; Jost CR; Koster AJ; Mei H; Míguez DG; Mulder AA; Ledesma-Terrón M; Pompilio G; Sala L; Salvatori DCF; Slieker RC; Sommariva E; de Vries AAF; Giera M; Semrau S; Tertoolen LGJ; Orlova VV; Bellin M; Mummery CL
    Cell Stem Cell; 2020 Jun; 26(6):862-879.e11. PubMed ID: 32459996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
    Yoshida A; Sekine W; Homma J; Sekine H; Itoyama YY; Sasaki D; Matsuura K; Kobayashi E; Shimizu T
    Regen Ther; 2022 Dec; 21():413-423. PubMed ID: 36248630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform.
    Lodrini AM; Barile L; Rocchetti M; Altomare C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.
    Yoshida S; Miyagawa S; Fukushima S; Kawamura T; Kashiyama N; Ohashi F; Toyofuku T; Toda K; Sawa Y
    Mol Ther; 2018 Nov; 26(11):2681-2695. PubMed ID: 30217728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supramolecular Assemblies of Glycopeptides Enhance Gap Junction Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes via Inducing Spheroids Formation to Optimize Cardiac Repair.
    Li H; Ye W; Yu B; Yan X; Lin Y; Zhan J; Chen P; Song X; Yang P; Cai Y
    Adv Healthc Mater; 2023 Oct; 12(25):e2300696. PubMed ID: 37338936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Characterization of Isogenic Cardiac Organoids from Human-Induced Pluripotent Stem Cells Under Supplement Starvation Regimen.
    Patino-Guerrero A; Ponce Wong RD; Kodibagkar VD; Zhu W; Migrino RQ; Graudejus O; Nikkhah M
    ACS Biomater Sci Eng; 2023 Feb; 9(2):944-958. PubMed ID: 36583992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure.
    Deicher A; Seeger T
    Curr Heart Fail Rep; 2021 Feb; 18(1):1-11. PubMed ID: 33215357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes.
    Forouzandehmehr M; Paci M; Hyttinen J; Koivumäki JT
    Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38516812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.
    Sachinidis A
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
    Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of MAPK and PI3K/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes.
    Garay BI; Givens S; Abreu P; Liu M; Yücel D; Baik J; Stanis N; Rothermel TM; Magli A; Abrahante JE; Goloviznina NA; Soliman HAN; Dhoke NR; Kyba M; Alford PW; Dudley SC; van Berlo JH; Ogle B; Perlingeiro RRC
    Stem Cell Reports; 2022 Sep; 17(9):2005-2022. PubMed ID: 35931076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maturation of hiPSC-derived cardiomyocytes promotes adult alternative splicing of SCN5A and reveals changes in sodium current associated with cardiac arrhythmia.
    Campostrini G; Kosmidis G; Ward-van Oostwaard D; Davis RP; Yiangou L; Ottaviani D; Veerman CC; Mei H; Orlova VV; Wilde AAM; Bezzina CR; Verkerk AO; Mummery CL; Bellin M
    Cardiovasc Res; 2023 Mar; 119(1):167-182. PubMed ID: 35394010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling.
    Vučković S; Dinani R; Nollet EE; Kuster DWD; Buikema JW; Houtkooper RH; Nabben M; van der Velden J; Goversen B
    Stem Cell Res Ther; 2022 Jul; 13(1):332. PubMed ID: 35870954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes.
    Peters MC; Maas RGC; van Adrichem I; Doevendans PAM; Mercola M; Šarić T; Buikema JW; van Mil A; Chamuleau SAJ; Sluijter JPG; Hnatiuk AP; Neef K
    Stem Cells Transl Med; 2022 Oct; 11(10):1040-1051. PubMed ID: 36018047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.